JZB-34

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameJZB-34
Drug Alias NameIgE-IgG Fc fusion protein (Shanghai Kexin Biotech)AAFPJZB-34
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionImmunoglobulin G inhibitorsImmunoglobulin E inhibitors
TargetsImmunoglobulin GImmunoglobulin E
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Kexin Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Kexin Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A